protein

CACNA1G

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CACNA1G: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

302Connections

1Hypotheses

1Analyses

50Outgoing

50Incoming

Summary

CACNA1G encodes Cav3.1, the alpha-1G subunit of low-voltage-activated T-type calcium channels involved in neuronal excitability and neurodegeneration.

View on Wiki →

🔬 Protein Info

Gene Symbol	CACNA1G
Full Name	Calcium Voltage-Gated Channel Subunit Alpha1 G
Chromosome	17q22
Protein Type	Ion Channel
Target Class	Ion Channel
Function	The CACNA1G gene encodes the α1G subunit that forms the pore of the T-type (low-voltage activated) calcium channel (CaV3.1).
Mechanism of Action	Small molecule blocker of T-type calcium channel activity
Druggability	High (0.90)
Clinical Stage	Approved
Molecular Weight	262 kDa
Pathways	Synaptic function / plasticity
UniProt ID	O43497
NCBI Gene ID	8912
Ensembl ID	ENSG00000006283
GeneCards	CACNA1G
Human Protein Atlas	CACNA1G
Associated Diseases	Ataxia, Autism, Epilepsy, Huntington's disease, SCA42ND, SCHIZOPHRENIA
Known Drugs/Compounds	Nnc-55-0396, SAK3
Interactions	KMT2A, ASXL1, COX6A2, ARID1A, LEF1, WNT3A
SciDEX Target	View Target Profile (8 clinical trials)
SciDEX Hypotheses	Sleep Spindle-Synaptic Plasticity Enhancement
KG Connections	302 knowledge graph edges
Databases	GeneCards HPA STRING

🔮 Predicted Structure: CACNA1G — AlphaFold O43497 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Pathway Diagram

graph TD
    CACNA1G["<b>CACNA1G</b>"]
    neurodegeneration{"neurodegeneration"}
    CACNA1G -->|"implicated in"| neurodegeneration
    CACNA1G -->|"associated with"| neurodegeneration
    ADORA2A["ADORA2A"]
    CACNA1G -->|"co discussed"| ADORA2A
    ADRA2A["ADRA2A"]
    CACNA1G -->|"co discussed"| ADRA2A
    h_8d270062["h-8d270062"]
    h_8d270062 -->|"therapeutic target"| CACNA1G
    h_8d270062 -->|"targets"| CACNA1G
    BMAL1["BMAL1"]
    BMAL1 -->|"co discussed"| CACNA1G
    HCRTR2["HCRTR2"]
    HCRTR2 -->|"co discussed"| CACNA1G
    CLOCK["CLOCK"]
    CLOCK -->|"co discussed"| CACNA1G
    BDNF["BDNF"]
    BDNF -->|"co discussed"| CACNA1G
    AQP4["AQP4"]
    AQP4 -->|"co discussed"| CACNA1G
    MTNR1A["MTNR1A"]
    MTNR1A -->|"co discussed"| CACNA1G
    CX3CR1["CX3CR1"]
    CX3CR1 -->|"co discussed"| CACNA1G
    HCRT["HCRT"]
    HCRT -->|"co discussed"| CACNA1G
    style CACNA1G fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (196)

Target	Relation	Type	Str
Amyloid Beta Production	mediates	process	0.90
Calcium Homeostasis	regulates	process	0.85
Alzheimer's Disease	risk_factor_for	disease	0.85
Pro-amyloidogenic Environment	protects_against	phenotype	0.80
cerebellum	expressed_in	brain_region	0.80
sleep_spindles	generates	phenotype	0.80
Schizophrenia	associated_with	disease	0.65
Cancer	activates	disease	0.65
Aging	activates	disease	0.65
Schizophrenia	inhibits	disease	0.65
Autism	inhibits	disease	0.65
Als	expressed_in	disease	0.65
Neurodegeneration	expressed_in	disease	0.65
Autism	associated_with	disease	0.65
Epilepsy	associated_with	disease	0.65
Tumor	biomarker_for	disease	0.65
Ataxia	associated_with	disease	0.65
Spinocerebellar Ataxia	associated_with	disease	0.65
ALS	expressed_in	disease	0.65
Ataxia	causes	disease	0.65
Spinocerebellar Ataxia	causes	disease	0.65
Aging	encodes	disease	0.65
Cancer	encodes	disease	0.65
neurodegeneration	implicated_in	disease	0.60
absence seizures	associated_with	disease	0.60
intellectual disability	associated_with	disease	0.60
schizophrenia	associated_with	disease	0.60
thalamic neurons	expressed_in	cell_type	0.60
SCA42ND	causes	disease	0.60
thalamus	expressed_in	brain_region	0.60
amyloid beta production	contributes_to	pathway	0.60
KMT2A	inhibits	gene	0.60
CALB1	biomarker_for	gene	0.60
RAB11	expressed_in	gene	0.60
TRKB	expressed_in	gene	0.60
Purkinje	associated_with	cell_type	0.60
ASXL1	activates	gene	0.60
COX6A2	activates	gene	0.60
ARID1A	activates	gene	0.60
CDKN2A	biomarker_for	gene	0.60
NEUROG1	biomarker_for	gene	0.60
MLH1	biomarker_for	gene	0.60
GAIN	associated_with	gene	0.60
LEF1	activates	gene	0.60
WNT3A	activates	gene	0.60
SETD1A	inhibits	gene	0.60
KMT2B	inhibits	gene	0.60
GAIN	expressed_in	gene	0.60
KMT2D	inhibits	gene	0.60
LEF1	expressed_in	gene	0.60

Incoming (106)

Source	Relation	Type	Str
Nnc-55-0396	inhibits	drug	0.90
Aging	downregulates	process	0.90
h-8d270062	targets_gene	hypothesis	0.90
h-8d270062	targets	hypothesis	0.80
LEF1	activates	protein	0.60
beta-catenin	activates	protein	0.60
SAK3	modulates	drug	0.60
CDKN2A	biomarker_for	gene	0.60
ARID1A	activates	gene	0.60
NEUROG1	biomarker_for	gene	0.60
TP53	activates	gene	0.60
APC	activates	gene	0.60
MLH1	biomarker_for	gene	0.60
PMS2	activates	gene	0.60
CAV3	associated_with	gene	0.60
GAIN	associated_with	gene	0.60
WNT3A	activates	gene	0.60
SETD1A	inhibits	gene	0.60
GAIN	expressed_in	gene	0.60
KMT2B	inhibits	gene	0.60
SHANK3	inhibits	gene	0.60
KMT2D	inhibits	gene	0.60
AXIN2	expressed_in	gene	0.60
CACNA1A	associated_with	gene	0.60
CCS	contributes_to	gene	0.60
CACNA1C	associated_with	gene	0.60
CACNA2D2	associated_with	gene	0.60
CACNA1F	associated_with	gene	0.60
CACNA1I	associated_with	gene	0.60
CACNA2D1	associated_with	gene	0.60
CACNA1E	associated_with	gene	0.60
CACNA1H	associated_with	gene	0.60
CACNA1D	associated_with	gene	0.60
SLC17A7	biomarker_for	gene	0.60
RAB7	expressed_in	gene	0.60
AKT	expressed_in	gene	0.60
RAB5	expressed_in	gene	0.60
KMT2A	inhibits	gene	0.60
RAB11	expressed_in	gene	0.60
CDKN2A	methylates	gene	0.60
ARID1A	encodes	gene	0.60
APC	encodes	gene	0.60
CALB1	biomarker_for	gene	0.60
TRKB	expressed_in	gene	0.60
CACNA1A	interacts_with	gene	0.60
CACNA1C	interacts_with	gene	0.60
CACNA1F	interacts_with	gene	0.60
DNA	biomarker_for	gene	0.60
KRAS	activates	gene	0.60
ANK3	inhibits	gene	0.60

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Sleep Spindle-Synaptic Plasticity Enhancement	0.491	neurodegeneration	Sleep disruption as cause and consequenc

Mentioning Analyses (1)

Scientific analyses that reference this entity

Sleep disruption as cause and consequence of neurodegeneration

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.557

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Effects of caffeine on sleep and cognition. [PMID:21531247]	Snel J, Lorist MM	Prog Brain Res	2011	1
Functional dissection of Timekeeper (Tik) implicates opposite roles for CK2 and [PMID:19536808]	Kunttas-Tatli E, Bose A, Kahali B, Bisho	Genesis	2009	1
CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the [PMID:41654970]	Lu W, Kawatani K, Ren Y	Alzheimers Res Ther	2026	0
Molecular brake on firing pattern transitions in MHbChAT neurons to mediate nico [PMID:41903536]	Zheng ZW, Min PX, Luo YL, Mao XF, Zhang	Neuron	2026	0
Presynaptic P/Q calcium channel deficit promotes postsynaptic excitability remod [PMID:41932329]	Thompson SJ, Miao QL, Sonig A, Noebels J	Neuron	2026	0
Estradiol modulates neuronal network hyperexcitability in select NDD risk genes. [PMID:41757108]	Pruitt A, Yang L, Lee S, Balafkan N, Sea	bioRxiv : the preprint server	2026	0
Vitamin D supplementation and COVID-19 risk: a population-based, cohort study. [PMID:34273098]	["Oristrell J", "Oliva J", "Casado E", "	Journal of endocrinological in	2022	0
Intracellular calcium homeostasis and its dysregulation underlying epileptic sei [PMID:36403388]	Zhou X, Chen Z, Xiao L, Zhong Y, Liu Y,	Seizure	2022	0
Homeostatic plasticity and burst activity are mediated by hyperpolarization-acti [PMID:33547341]	Rátkai A, Tárnok K, Aouad HE, Micska B,	Scientific reports	2021	0
Machine learning reveals bilateral distribution of somatic L1 insertions in huma [PMID:33432196]	["Zhu X", "Zhou B", "Pattni R", "Gleason	Nature neuroscience	2021	0
Cryo-EM structures of full-length Tetrahymena ribozyme at 3.1 Å resolution. [PMID:34381213]	["Su Z", "Zhang K", "Kappel K", "Li S",	Nature	2021	0
Prevalence and follow-up of potentially inappropriate medication and potentially [PMID:32641251]	["van Loveren F", "van Berlo-van de Laar	Journal of geriatric oncology	2021	0
Neuronal Cav3 channelopathies: recent progress and perspectives. [PMID:32638069]	Lory P, Nicole S, Monteil A	Pflugers Archiv : European jou	2020	0
Single-cell epigenomic analyses implicate candidate causal variants at inherited [PMID:33106633]	["Corces M", "Shcherbina A", "Kundu S",	Nature genetics	2020	0
Reciprocal associations between depression, anxiety and work-related injury. [PMID:31685530]	["Gerasimaviciute V", "B\u00fcltmann U",	Injury prevention : journal of	2020	0
On-surface synthesis of planar dendrimers via divergent cross-coupling reaction. [PMID:31160575]	["Li D", "Li S", "Xie Y", "Hua X", "Long	Nature communications	2019	0
STAT4 Directs a Protective Innate Lymphoid Cell Response to Gastrointestinal Inf [PMID:31562212]	["Dulson S", "Watkins E", "Crossman D",	Journal of immunology (Baltimo	2019	0
Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of ep [PMID:29728119]	["Ayg\u00f6ren-P\u00fcrs\u00fcn E", "Mag	Orphanet journal of rare disea	2018	0
Predictors of Extended Length of Hospital Stay Following Surgical Repair of Cong [PMID:30171266]	["Azhar A", "Aljefri H"]	Pediatric cardiology	2018	0
Interstitial lung abnormalities and self-reported health and functional status. [PMID:29317545]	["Axelsson G", "Putman R", "Araki T", "S	Thorax	2018	0

CACNA1G

Understanding Entity Pages

Summary

Wiki Pages (21)

CACNA1G Gene

Ion Channel Dysfunction in Parkinson's Disease

CALB1 (Calbindin 1)

PMS2 — DNA Mismatch Repair Protein PMS2

Thalamic Reticular Nucleus in Epilepsy

Globus Pallidus Externus GABAergic Neurons

voltage-gated-calcium-channel-neurons

CBS/PSP Sleep Disorders Management

PD Ion Channel Modulator Companies

Calcium Channel Dysfunction in Parkinson's Disease

Alzheimer's Disease Calcium Channel and Homeostasis Therapy Companies

NEUROG1 (Neurogenin-1)

Calcium Channel Dysfunction in Neurodegeneration

Alzheimer's Disease Ion Channel Modulator Companies

Pontine Nuclei

CACNA1G Protein - Cav3.1 T-type Calcium Channel

Spinal Vestibular Nucleus (SpVN) Expanded

Red Nucleus Neurons

Accerise Inc.

CACNA1D Gene